Sm-p80 Schistosomiasis Challenge Study

NCT05999825 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Schistosoma Mansoni
Schistosomiasis

Interventions

BIOLOGICAL: Sm-p80 + GLA-SE Vaccine
OTHER: Placebo
BIOLOGICAL: Schistosoma mansoni infection

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]